Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 12, 2016
Daiichi Sankyo Company, Limited and the Dana-Farber Cancer Institute have announced a preclinical research collaboration focused on lung cancer.
read more
Thursday, October 14, 2021
The Department of Air Force, in coordination with the Department of Health and Human Services (HHS), awarded a $30 million contract to Eurofins Genomics US to build a new production facility and expanded capacity for the manufacturing of reagents ...
read more
Friday, November 01, 2019
Atlanta is now Dachser's fourth location to receive certification in ten months, further expanding the company's network services for its customers in the life science and healthcare sector.
read more
Following Frankfurt, Atlanta, Mumbai, and Hyderabad, Shanghai is now Dachser’s fifth location to receive a CEIV certification, further expanding the company’s network services for its customers in the life science and healthcare (LSH) sector.
...
read more
Thursday, September 13, 2018
CytRx has received a milestone payment of $250,000 from Orphazyme A/S.
read more
Wednesday, October 31, 2012
Cytovance Biologics, Inc. and Fountain BioPharma, Inc. jointly announce the execution of a Biopharmaceutical Development and Manufacturing collaboration for FB301, a novel monoclonal antibody (mAb) being developed for the treatment of allergy as a ...
read more
Cytovance® Biologics announced the appointment of Jesse McCool, Ph.D. as Chief Technology Officer.
read more
Cytovance® Biologics, a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces Don Wuchterl as the new Senior Vice President of Manufacturing Operations
read more
Cytovance Biologics, Inc. announces that it has teamed up with NeuroFx to develop and manufacture stem cell derived, cell-free therapy for neurological conditions.
read more
Cytovance Biologics, Inc., a leading full-service contract manufacturer ("CMO") of mammalian and microbial biologics, is pleased to participate in the Buzz of BIO for the 2014 BIO International Convention. Hosted by the Biotechnology Industry ...
read more
Wednesday, January 14, 2015
Cytovance® Biologics, Inc., a leading biopharmaceutical contract manufacturing company, announced the promotion of Donald Wuchterl to Chief Operating Officer. In this new capacity, Mr. Wuchterl will oversee Cytovance's Research & Development Services...
read more
Wednesday, January 14, 2015
Cytovance Biologics, Inc. is pleased to announce the appointment of Seth Fisher as Director of Purification Development in the R&D Services group.
read more
Cytovance Biologics, Inc., a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces a development and manufacturing agreement with Selexys Pharmaceuticals, Corp., an Oklahoma City-based clinical stage ...
read more
Thursday, February 27, 2014
Cytovance Biologics, Inc., a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces that they have entered into a development and manufacturing agreement with Pamlico Biopharma, Inc., an Oklahoma City-based...
read more
Thursday, October 03, 2013
Cytovance Biologics, a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces that they have entered into a manufacturing agreement with Translational Sciences, Inc., a Memphis, Tennessee-based clinical ...
read more